These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29771315)

  • 21. Personal Cancer Genome Reporter: variant interpretation report for precision oncology.
    Nakken S; Fournous G; Vodák D; Aasheim LB; Myklebost O; Hovig E
    Bioinformatics; 2018 May; 34(10):1778-1780. PubMed ID: 29272339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference.
    Matsutani T; Ueno Y; Fukunaga T; Hamada M
    Bioinformatics; 2019 Nov; 35(22):4543-4552. PubMed ID: 30993319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal origins and parallel evolution of regionally synchronous colorectal adenoma and carcinoma.
    Kim TM; An CH; Rhee JK; Jung SH; Lee SH; Baek IP; Kim MS; Lee SH; Chung YJ
    Oncotarget; 2015 Sep; 6(29):27725-35. PubMed ID: 26336987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
    Phillips DH
    DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIApopr: a computational method to simulate evolutionary branching trees for analysis of tumor clonal evolution.
    McDonald TO; Michor F
    Bioinformatics; 2017 Jul; 33(14):2221-2223. PubMed ID: 28334409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
    Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
    Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Driver gene mutations based clustering of tumors: methods and applications.
    Zhang W; Flemington EK; Zhang K
    Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ncdDetect2: improved models of the site-specific mutation rate in cancer and driver detection with robust significance evaluation.
    Juul M; Madsen T; Guo Q; Bertl J; Hobolth A; Kellis M; Pedersen JS
    Bioinformatics; 2019 Jan; 35(2):189-199. PubMed ID: 29945188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simulation of heterogeneous tumour genomes with HeteroGenesis and in silico whole exome sequencing.
    Tanner G; Westhead DR; Droop A; Stead LF
    Bioinformatics; 2019 Aug; 35(16):2850-2852. PubMed ID: 30615054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.
    Harbst K; Lauss M; Cirenajwis H; Isaksson K; Rosengren F; Törngren T; Kvist A; Johansson MC; Vallon-Christersson J; Baldetorp B; Borg Å; Olsson H; Ingvar C; Carneiro A; Jönsson G
    Cancer Res; 2016 Aug; 76(16):4765-74. PubMed ID: 27216186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MutEnricher: a flexible toolset for somatic mutation enrichment analysis of tumor whole genomes.
    Soltis AR; Dalgard CL; Pollard HB; Wilkerson MD
    BMC Bioinformatics; 2020 Jul; 21(1):338. PubMed ID: 32736515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genomic characterization of mutational signatures across human cancers.
    Liao J; Bai J; Pan T; Zou H; Gao Y; Guo J; Xu Q; Xu J; Li Y; Li X
    Int J Cancer; 2023 Apr; 152(8):1613-1629. PubMed ID: 36533638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.
    Díaz-Gay M; Vila-Casadesús M; Franch-Expósito S; Hernández-Illán E; Lozano JJ; Castellví-Bel S
    BMC Bioinformatics; 2018 Jun; 19(1):224. PubMed ID: 29898651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.
    Das S; Deng X; Camphausen K; Shankavaram U
    Bioinformatics; 2019 Feb; 35(4):701-702. PubMed ID: 30059974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.
    Gendoo DM; Ratanasirigulchai N; Schröder MS; Paré L; Parker JS; Prat A; Haibe-Kains B
    Bioinformatics; 2016 Apr; 32(7):1097-9. PubMed ID: 26607490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canvas: versatile and scalable detection of copy number variants.
    Roller E; Ivakhno S; Lee S; Royce T; Tanner S
    Bioinformatics; 2016 Aug; 32(15):2375-7. PubMed ID: 27153601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
    Shiraishi Y; Tremmel G; Miyano S; Stephens M
    PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. tugHall: a simulator of cancer-cell evolution based on the hallmarks of cancer and tumor-related genes.
    Nagornov IS; Kato M
    Bioinformatics; 2020 Jun; 36(11):3597-3599. PubMed ID: 32170925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PhySigs: Phylogenetic Inference of Mutational Signature Dynamics.
    Christensen S; Leiserson MDM; El-Kebir M
    Pac Symp Biocomput; 2020; 25():226-237. PubMed ID: 31797599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using sigLASSO to optimize cancer mutation signatures jointly with sampling likelihood.
    Li S; Crawford FW; Gerstein MB
    Nat Commun; 2020 Jul; 11(1):3575. PubMed ID: 32681003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.